Celiac test kits match multi-centre study demands

The results of the recent Multi-Centre Celiac Serology Study undertaken to define the optimal serological screening approach to Celiac Disease clearly showed that dual or combined isotype (IgA+IgG) transglutaminase screening can be advocated as a sensitive and specific alternative to endomysial antibody testing in the assessment of Celiac Disease.

The manufacturer Aesku Diagnotics reports that its AESKULISA tTg ELISA kits ‘performed excellently’, and the AESKULISA Celicheck was ‘even placed first as the best dual isotype transglutaminase kit of all assays tested.’ The Elisa kits have a unique composition, the firm explains. ‘Human recombinant tissue transglutaminase is cross-linked with gliadin-specific peptides resulting in the creation of neo-epitopes of tTg. The tests are highly specific as no cross-reactions with gliadin occur.’
* The FDA has approved the improved Aeskulisa tTg IgA and tTg IgG tests for the detection of tissue transglutaminase (tTg) antibodies.
 

20.11.2008

More on the subject:

Related articles

Photo

News • Neuroprotective antiviral state in the CNS

Remarkable early warning system helps the brain prepare for a viral attack

Virus-associated molecules in the foot are enough to trigger the network: Research reveals a remarkable mechanism, in which the brain prepares for a potential viral attack within hours of infection.

Photo

News • Fluorescence lifetime imaging microscopy

New technique could aid targeted lung cancer treatment

Detecting genetic mutations associated with lung cancer via laboratory tests can be expensive and time-consuming, and use up valuable tissue from small biopsy samples. A new approach aims to fix this.

Photo

News • Biological scaffolds of cellulose and soy

Sustainable material to regenerate cartilage damage

Researchers have developed structures for cartilage regeneration based on cellulose, gelatin and soy proteins obtained from food industry by-products, with promising properties for tissue engineering.

Subscribe to Newsletter